+148.5%
MRNA vs GH
+73.4%
+75.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 6mo.
| Period | Portfolio | GH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.7% | -2.3% | +3.0% | +2.2% |
| 7D | -8.2% | -1.2% | -7.0% | -7.6% |
| 30D | +125.6% | -3.7% | +129.2% | +130.5% |
| 3M | +197.1% | +21.7% | +175.4% | +175.1% |
| 6M | +148.5% | +75.7% | +72.7% | +96.8% |
| All | +148.5% | +73.4% | +75.1% | +96.8% |
Cumulative growth
Daily Returns
Daily percentage return beside GH.
Daily Out/Under-Performance
Portfolio return minus GH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × GH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 6mo: compounded portfolio wealth divided by compounded GH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
6mo analysis · Full analysis span regression · 6 months rolling